The Biology of DHFR Deficiency
At a Glance
DHFR deficiency is a rare inherited disorder in which both copies of the DHFR gene impair folate activation. Low active folate disrupts DNA production, leading to megaloblastic anemia and neurologic problems; high homocysteine with normal MMA can support the diagnosis, but genetic testing is needed.
To understand DHFR deficiency, it helps to look at your child’s cells as a highly active construction site. To build DNA and grow new cells, the body needs a specific “active” form of folate (Vitamin B9) [1].
The DHFR enzyme acts as a crucial converter in this process. It reduces dihydrofolate (and standard folic acid) into tetrahydrofolate (THF), an active form that the body can use for cellular growth and brain function [2]. In children with DHFR deficiency, this conversion machinery is broken at the molecular level, causing a shortage of the raw materials needed for life’s most basic building blocks [3].
The Genetics: DHFR Variants
This condition is caused by variants in the DHFR gene. We are all born with two copies of this gene—one from each parent. For a child to have this condition, they must have biallelic pathogenic variants, meaning both copies of the gene carry changes that disrupt the enzyme’s function [3].
While several different mutations can occur, research in specific variants (like p.Gly18Val and p.Pro26Leu) has shown how the defect can operate:
- Rapid Degradation: In some studied variants, the genetic “typo” makes the DHFR protein physically unstable. The cell’s internal quality control system recognizes it as defective and destroys it (proteasomal degradation) before it can properly process folate [4][3].
Why It Affects the Blood and Brain
Because the conversion process is impaired, the pool of active folate (THF) diminishes. This has a “domino effect” on the body’s chemistry:
- DNA Synthesis Failure: Without active folate, the body cannot efficiently make the “rungs” of the DNA ladder (purines and pyrimidines) [2].
- Megaloblastic Anemia: Bone marrow cells, which divide very quickly, are hit hardest. They try to grow but cannot finish copying their DNA, resulting in the oversized, immature red blood cells characteristic of this condition [3][5].
- Neurological Impact: The brain also relies on these “one-carbon” chemical reactions. While the exact mechanisms are complex, a severe lack of active folate in the nervous system is believed to contribute to the seizures and developmental delays seen in these children [6].
Differentiating from “Look-Alikes”
Because the symptoms (like anemia and seizures) can look identical to other conditions, doctors use specific chemical markers in the blood and urine to tell them apart. Two of the most important markers are homocysteine and methylmalonic acid (MMA).
Cobalamin (B12) Processing Disorders
Conditions like cblC and cblD are often confused with DHFR deficiency because they also cause megaloblastic anemia and neurological issues [7][8].
- The Difference: In cblC, the body cannot process Vitamin B12. This typically causes a backup of two different chemicals: homocysteine and methylmalonic acid (MMA) [7]. (Note: cblD has distinct subtypes that may vary in their MMA and homocysteine presentation).
- DHFR Profile: In DHFR deficiency, the MMA level is typically normal. While homocysteine is often high because the folate and B12 pathways are linked, the normal MMA helps point doctors toward a folate-specific defect rather than a generalized B12 absorption issue [3][9].
Thiamine-Responsive Megaloblastic Anemia (TRMA)
TRMA (caused by a mutation in the SLC19A2 gene) is another rare genetic cause of anemia [10].
- The Difference: Children with TRMA usually have normal levels of both B12 and folate pathways. They also typically develop diabetes and hearing loss, which are not characteristic of DHFR deficiency [11][12].
Nutritional vs. Genetic Deficiency
- Nutritional B12 Deficiency: Can cause high homocysteine and high MMA [13].
- Nutritional Folate Deficiency: Can cause high homocysteine but normal MMA [13].
- DHFR Deficiency: Like nutritional folate deficiency, it may show normal MMA, but it does not improve with simple dietary changes because the metabolic enzyme is fundamentally defective [3].
Biochemical Marker Comparison Table
(Note: These markers support the diagnosis but are not definitively diagnostic on their own; molecular genetic testing is required, and lab values can fluctuate based on age, kidney function, and treatment).
| Condition | Homocysteine | Methylmalonic Acid (MMA) | Primary Issue |
|---|---|---|---|
| DHFR Deficiency | Often High | Normal | Folate Enzyme Defect |
| Nutritional B12 Def. | High | High | Lack of Vitamin B12 Intake |
| cblC Disorder | High | High | Genetic B12 Processing Defect |
| TRMA | Normal | Normal | Thiamine Transport Defect |
Understanding these biochemical patterns helps explain how your medical team works to confirm that your child’s symptoms are caused by the DHFR gene [9][14].
Common questions in this guide
What does DHFR deficiency do in the body?
What genetic result is needed to diagnose DHFR deficiency?
What do homocysteine and MMA results mean in DHFR deficiency?
How is DHFR deficiency different from TRMA?
Why can DHFR deficiency cause both anemia and neurologic problems?
Can nutritional folate or vitamin B12 deficiency look like DHFR deficiency?
Get notified when new evidence is published on Constitutional megaloblastic anemia with severe neurologic disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
DHFR2 RNA directly regulates dihydrofolate reductase and its expression level impacts folate one carbon metabolism.
Drago P, Bookey N, Leung KY, et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025; (39(4)):e70391 doi:10.1096/fj.202401039RR.
PMID: 39957677 - 2
Evolutionarily Related Dihydrofolate Reductases Perform Coequal Functions Yet Show Divergence in Their Trajectories.
Rashid N, Chaudhuri Chattopadhyay P
The protein journal 2018; (37(4)):301-310 doi:10.1007/s10930-018-9784-8.
PMID: 30019321 - 3
Identification of novel disease-causing variants and their influence on clinical presentation in dihydrofolate reductase deficiency.
Wang D, Zhou D, Zhang Y, et al.
Neuroscience 2025; (583()):84-92 doi:10.1016/j.neuroscience.2025.07.045.
PMID: 40752814 - 4
Disease-linked mutations cause exposure of a protein quality control degron.
Kampmeyer C, Larsen-Ledet S, Wagnkilde MR, et al.
Structure (London, England : 1993) 2022; (30(9)):1245-1253.e5 doi:10.1016/j.str.2022.05.016.
PMID: 35700725 - 5
Acquired Vitamin B12 Deficiency in Newborns: Positive Impact on Newborn Health through Early Detection.
Lipari Pinto P, Florindo C, Janeiro P, et al.
Nutrients 2022; (14(20)) doi:10.3390/nu14204397.
PMID: 36297083 - 6
Cerebral folate deficiency: Analytical tests and differential diagnosis.
Pope S, Artuch R, Heales S, Rahman S
Journal of inherited metabolic disease 2019; (42(4)):655-672 doi:10.1002/jimd.12092.
PMID: 30916789 - 7
Evaluation of the clinical, biochemical, and molecular spectrum of Cobalamin C (CblC) defect in 33 patients from Pakistan.
Ahmed S, Cai L, Akbar F, et al.
Scandinavian journal of clinical and laboratory investigation 2024; (84(6)):391-397 doi:10.1080/00365513.2024.2394983.
PMID: 39225018 - 8
Clinical, Biochemical and Molecular Features of a Cohort of 8 Patients with Inherited Disorders of Vitamin B12 Metabolism in a Metabolic Reference Center.
Padeira G, Jacinto S, Ribeirinho A, Ferreira AC
Endocrine, metabolic & immune disorders drug targets 2023; doi:10.2174/0118715303272253231004094018.
PMID: 37861032 - 9
First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.
Olivieri G, Bordugo A, Burnyte B, et al.
Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.
PMID: 42231716 - 10
Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic Neoplasm.
Klötzer C, Schnabel F, Kubasch AS, et al.
Acta haematologica 2025; (148(4)):380-385 doi:10.1159/000542286.
PMID: 39467528 - 11
[Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Lu H, Lu H, Vaucher J, et al.
La Revue de medecine interne 2019; (40(1)):20-27 doi:10.1016/j.revmed.2018.06.005.
PMID: 30031565 - 12
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
Di Candia F, Di Iorio V, Tinto N, et al.
Italian journal of pediatrics 2023; (49(1)):158 doi:10.1186/s13052-023-01553-1.
PMID: 38037112 - 13
Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency.
Hannibal L, Lysne V, Bjørke-Monsen AL, et al.
Frontiers in molecular biosciences 2016; (3()):27 doi:10.3389/fmolb.2016.00027.
PMID: 27446930 - 14
An infant with an extremely rare cobalamin disorder: Methionine synthase deficiency and importance of early diagnosis and treatment.
Kasapkara ÇS, Yılmaz-Keskin E, Özbay-Hoşnut F, et al.
The Turkish journal of pediatrics 2019; (61(2)):282-285.
PMID: 31951343
This page is for informational purposes only and does not constitute medical advice. Your child's genetics and medical team should interpret DHFR, homocysteine, MMA, and genetic test results for their specific situation.